Tempest Therapeutics, Inc. Accumulated Other Comprehensive Income
Tempest Therapeutics, Inc. (TPST) had Accumulated Other Comprehensive Income of -$89.00 thousand as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2021-11-10
- 2021-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$89.00K.
- 2021-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $277.00K.
- 2020-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $452.00K.
- 2020-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00; Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed $274.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2021-09-30 | -$89.00K 10-Q · filed 2021-11-10 | |
| 2021-03-31 | $277.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $452.00K 10-Q · filed 2021-05-13 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | $274.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $118.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $123.00K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $165.00K 10-K · filed 2021-03-29 | |
| 2019-09-30 | $123.00K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $140.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $139.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $148.00K 10-K · filed 2020-03-11 | |
| 2018-09-30 | -$3.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | -$9.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$31.00K 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $8.00K 10-K · filed 2019-04-01 | -$27.00K 10-K · filed 2018-03-15 |
| 2017-09-30 | -$21.00K 10-Q · filed 2017-11-02 | |
| 2017-06-30 | -$49.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | -$59.00K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | -$60.00K 10-K · filed 2018-03-15 | |
| 2016-09-30 | -$22.00K 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $9.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | -$7.00K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | -$170.00K 10-K · filed 2017-03-02 | |
| 2015-09-30 | -$72.00K 10-Q · filed 2015-11-05 | |
| 2015-06-30 | -$94.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | -$1.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$26.00K 10-K · filed 2016-02-26 | |
| 2014-09-30 | -$24.00K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | -$8.00K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | -$3.00K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $10.00K 10-K · filed 2015-03-16 | |
| 2013-09-30 | $3.00K 10-Q · filed 2013-11-13 | |
| 2013-06-30 | -$26.00K 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $1.00K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$6.00K 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |